Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 30, 2023
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
Mon, May 29, 2023
[ Mon, May 29th 2023
] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy and Held Target at $45 on, May 29th, 2023
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $45 on, May 29th, 2023.
Bradley has made no other calls on ZNTL in the last 4 months.
There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Bradley
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $55 on, Friday, May 26th, 2023
- Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $50 on, Friday, May 26th, 2023
- Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $38 on, Friday, May 26th, 2023
- Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023
